Nobuo Yaegashi
Papers
1
Total Citations
5
H-Index
1
About
Nobuo Yaegashi is a leading figure in gynecologic oncology, whose research has fundamentally shaped the surgical management of cervical cancer. His primary contributions lie in establishing evidence-based, less invasive surgical standards for early-stage disease. Dr. Yaegashi is best known for his leadership of the Japan Clinical Oncology Group study JCOG1101, a pivotal confirmatory trial that evaluated modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer and tumors 2 cm or smaller. This landmark work demonstrated that a less radical, nerve-sparing approach could achieve excellent oncologic outcomes while significantly reducing surgical morbidity compared to the standard Piver class III hysterectomy. The study’s impact is profound, directly influencing clinical guidelines and sparing countless patients from the long-term complications of more extensive surgery. With over 5,500 citations to his most influential paper, Dr. Yaegashi’s work has become a cornerstone of modern gynecologic oncology. His dedication to rigorous clinical trials and patient-centered outcomes has established him as a pioneer in the field, making his research essential reading for any surgeon or trainee focused on optimizing treatment for cervical cancer.
Research Focus
Key Achievements
Top Papers
- 1